Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014)

Bausch Health Companies (BHC) reported Non Operating Investment Income of $2.5 million for Q2 2014, down 35.9% on a YoY basis from $3.9 million in Q2 2013, and down 35.9% sequentially from $3.9 million in Q2 2013.

Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014) Analysis & Trends

Bausch Health Companies (BHC) has 5 years of Non Operating Investment Income data on file, last reported at $2.5 million in Q2 2014.

  • For the quarter ending Q2 2014, Non Operating Investment Income fell 35.9% year-over-year to $2.5 million; the trailing twelve-month figure through Jun 2015 stood at $2.5 million (down 60.94% YoY), and the FY2014 full-year result was $293.0 million, up 4951.72% from the prior year.
  • Non Operating Investment Income eased to $2.5 million in Q2 2014, from $3.9 million in the prior quarter.
  • In the past five years, Non Operating Investment Income ranged from a high of $21.2 million in Q2 2011 to a low of -$5.0 million in Q3 2010.
  • A 5-year average of $2.1 million and a median of $76000.0 in 2012 frame the typical range for Non Operating Investment Income.
  • Across the five-year window, Non Operating Investment Income sank 100.17% in 2012 and soared 11242.86% in 2013, its largest moves.
  • Tracing BHC's Non Operating Investment Income over 5 years: stood at -$5.0 million in 2010, then soared by 99.78% to -$11000.0 in 2011, then surged by 790.91% to $76000.0 in 2012, then soared by 5031.58% to $3.9 million in 2013, then plunged by 35.9% to $2.5 million in 2014.
  • Business Quant data shows BHC's Non Operating Investment Income at $2.5 million in Q2 2014, $3.9 million in Q2 2013, and $1.9 million in Q1 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn -
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Bausch Health Companies 1.68 Bn 367.46 Mn 2.52 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2014 2.50 Mn
Jun 30, 2014 2.50 Mn
Jun 30, 2013 3.90 Mn
Jun 30, 2013 3.90 Mn
Mar 31, 2013 1.86 Mn
Mar 31, 2013 1.86 Mn
Dec 31, 2012 76,000.00
Dec 31, 2012 76,000.00
Jun 30, 2012 -35,000.00
Jun 30, 2012 -35,000.00
Mar 31, 2012 2.06 Mn
Mar 31, 2012 2.06 Mn
Dec 31, 2011 -11,000.00
Dec 31, 2011 -11,000.00
Sep 30, 2011 -140,000.00
Sep 30, 2011 -140,000.00
Jun 30, 2011 21.16 Mn
Jun 30, 2011 21.16 Mn
Mar 31, 2011 1.77 Mn
Mar 31, 2011 1.77 Mn